ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 50 filers reported holding ALBIREO PHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $51,000 | +410.0% | 2,397 | +398.3% | 0.00% | – |
Q3 2022 | $10,000 | +233.3% | 481 | +270.0% | 0.00% | – |
Q2 2022 | $3,000 | -90.3% | 130 | -87.5% | 0.00% | – |
Q1 2022 | $31,000 | -64.4% | 1,036 | -72.4% | 0.00% | – |
Q4 2021 | $87,000 | +93.3% | 3,750 | +159.5% | 0.00% | – |
Q3 2021 | $45,000 | 0.0% | 1,445 | +15.1% | 0.00% | – |
Q2 2021 | $45,000 | +9.8% | 1,255 | +8.9% | 0.00% | – |
Q1 2021 | $41,000 | +2.5% | 1,152 | +8.5% | 0.00% | – |
Q4 2020 | $40,000 | +135.3% | 1,062 | +109.5% | 0.00% | – |
Q3 2020 | $17,000 | 0.0% | 507 | -19.4% | 0.00% | – |
Q2 2020 | $17,000 | +466.7% | 629 | +288.3% | 0.00% | – |
Q1 2020 | $3,000 | -83.3% | 162 | -75.9% | 0.00% | – |
Q4 2019 | $18,000 | +800.0% | 672 | +572.0% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | +50.0% | 100 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -77.8% | 100 | -63.4% | 0.00% | – |
Q3 2018 | $9,000 | +28.6% | 273 | +54.2% | 0.00% | – |
Q2 2018 | $7,000 | +133.3% | 177 | +77.0% | 0.00% | – |
Q1 2018 | $3,000 | – | 100 | +900.0% | 0.00% | – |
Q4 2017 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |